The Hidden Hazard of Hypothyroidism: Statin-Associated Rhabdomyolysis With Life-Threatening Complications.

IF 1.3 Q3 MEDICINE, GENERAL & INTERNAL
Cureus Pub Date : 2025-06-07 eCollection Date: 2025-06-01 DOI:10.7759/cureus.85506
George Bechir, Angelina Bechir
{"title":"The Hidden Hazard of Hypothyroidism: Statin-Associated Rhabdomyolysis With Life-Threatening Complications.","authors":"George Bechir, Angelina Bechir","doi":"10.7759/cureus.85506","DOIUrl":null,"url":null,"abstract":"<p><p>Statins are among the most widely prescribed medications for reducing cardiovascular morbidity and mortality. While generally well tolerated, they carry a rare but potentially fatal risk of rhabdomyolysis - a condition marked by massive skeletal muscle breakdown, electrolyte abnormalities, and acute kidney injury (AKI). We report the case of a 76-year-old man who developed profound rhabdomyolysis, severe transaminitis, and dialysis, requiring AKI shortly after initiating atorvastatin. His initial symptoms included excruciating bilateral lower extremity pain and progressive weakness, ultimately rendering him unable to walk. Laboratory evaluation revealed a creatine kinase level exceeding 25,000 U/L, marked elevations in aspartate aminotransferase (AST) and alanine aminotransferase (ALT), and a creatinine of 9.6 mg/dL. Despite prompt initiation of aggressive intravenous hydration, bladder decompression, and supportive care, the patient remained anuric and progressed to volume overload, necessitating initiation of hemodialysis. Further evaluation revealed profoundly uncontrolled hypothyroidism, with a thyroid-stimulating hormone (TSH) of 121.7 µIU/mL and a free T4 level of less than 0.4 ng/dL, despite reported use of levothyroxine. MRI of the thigh showed diffuse muscular edema without myonecrosis, and an autoimmune myositis panel was negative. Atorvastatin was promptly discontinued, and thyroid hormone therapy was intensified. Over the next several days, his biochemical parameters slowly improved, and he was ultimately discharged to acute rehabilitation with plans for outpatient dialysis and endocrine follow-up. This case underscores the synergistic danger of statin therapy in the presence of untreated or undertreated hypothyroidism. Routine screening for thyroid dysfunction, particularly in elderly patients or those with known thyroid disease, may help prevent catastrophic complications such as rhabdomyolysis and irreversible renal injury.</p>","PeriodicalId":93960,"journal":{"name":"Cureus","volume":"17 6","pages":"e85506"},"PeriodicalIF":1.3000,"publicationDate":"2025-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12145068/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cureus","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7759/cureus.85506","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Statins are among the most widely prescribed medications for reducing cardiovascular morbidity and mortality. While generally well tolerated, they carry a rare but potentially fatal risk of rhabdomyolysis - a condition marked by massive skeletal muscle breakdown, electrolyte abnormalities, and acute kidney injury (AKI). We report the case of a 76-year-old man who developed profound rhabdomyolysis, severe transaminitis, and dialysis, requiring AKI shortly after initiating atorvastatin. His initial symptoms included excruciating bilateral lower extremity pain and progressive weakness, ultimately rendering him unable to walk. Laboratory evaluation revealed a creatine kinase level exceeding 25,000 U/L, marked elevations in aspartate aminotransferase (AST) and alanine aminotransferase (ALT), and a creatinine of 9.6 mg/dL. Despite prompt initiation of aggressive intravenous hydration, bladder decompression, and supportive care, the patient remained anuric and progressed to volume overload, necessitating initiation of hemodialysis. Further evaluation revealed profoundly uncontrolled hypothyroidism, with a thyroid-stimulating hormone (TSH) of 121.7 µIU/mL and a free T4 level of less than 0.4 ng/dL, despite reported use of levothyroxine. MRI of the thigh showed diffuse muscular edema without myonecrosis, and an autoimmune myositis panel was negative. Atorvastatin was promptly discontinued, and thyroid hormone therapy was intensified. Over the next several days, his biochemical parameters slowly improved, and he was ultimately discharged to acute rehabilitation with plans for outpatient dialysis and endocrine follow-up. This case underscores the synergistic danger of statin therapy in the presence of untreated or undertreated hypothyroidism. Routine screening for thyroid dysfunction, particularly in elderly patients or those with known thyroid disease, may help prevent catastrophic complications such as rhabdomyolysis and irreversible renal injury.

甲状腺功能减退的隐患:他汀类药物相关横纹肌溶解伴危及生命的并发症。
他汀类药物是用于降低心血管发病率和死亡率的最广泛的处方药之一。虽然通常耐受性良好,但它们具有罕见但潜在致命的横纹肌溶解风险——一种以大量骨骼肌破裂、电解质异常和急性肾损伤(AKI)为特征的疾病。我们报告一位76岁的男性患者,他出现了深度横纹肌溶解、严重的转氨炎和透析,在开始阿托伐他汀治疗后不久需要AKI。他最初的症状包括双侧下肢剧烈疼痛和进行性虚弱,最终使他无法行走。实验室评估显示肌酸激酶水平超过25,000 U/L,谷草转氨酶(AST)和丙氨酸转氨酶(ALT)明显升高,肌酐为9.6 mg/dL。尽管立即开始积极的静脉补水、膀胱减压和支持性护理,患者仍然无尿并进展为容量超载,需要开始血液透析。进一步评估显示甲状腺功能减退严重失控,促甲状腺激素(TSH)为121.7 μ IU/mL,游离T4水平低于0.4 ng/dL,尽管报告使用左甲状腺素。大腿MRI显示弥漫性肌肉水肿,无肌坏死,自身免疫性肌炎阴性。立即停用阿托伐他汀,并加强甲状腺激素治疗。在接下来的几天里,他的生化指标慢慢改善,最终出院进行急性康复,并计划进行门诊透析和内分泌随访。本病例强调了他汀类药物治疗在未治疗或治疗不足的甲状腺功能减退患者中的协同危险。常规筛查甲状腺功能障碍,特别是对老年患者或已知甲状腺疾病的患者,可能有助于预防灾难性并发症,如横纹肌溶解和不可逆肾损伤。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信